Brief: Champions Oncology Q3 Non-GAAP loss per share $0.21

Champions Oncology

15/03/2016 12:30

March 15 (Reuters) - Champions Biotechnology  Inc  CSBR.O  
    * Q3 Non-GAAP loss per share $0.21 
    * Champions Oncology reports results for the third quarter 
ended January 31, 2016 
    * Q3 revenue $2.6 million 
 
  Source text for Eikon:  ID:nPn3wgdvX  
  Further company coverage:  CSBR.O  
 
 ((Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 
8780))